TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24798710

Group type: EXPERIMENTAL
Intervention: Extended Intervention (EI)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Basic Intervention (BI)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control
Number of subjects: 205
Study: 22907790

Group type: EXPERIMENTAL
Intervention: 240 ml daily of 100% Concord grape juice
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 20921939

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Both ETV and ADV
Number of subjects: 57
Study: 19893995

Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
Number of subjects: 985
Study: 17300239

Group type: EXPERIMENTAL
Intervention: Simplified creams
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Lipid-free gel
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Ordinary cream (5% urea)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: One of the simplified creams
Number of subjects: 78

Group type: COMPARATOR
Intervention: All test preparations
Number of subjects: 78
Study: 16624688

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg intravenously, equivalent to 2 cups of coffee)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 10
Study: 12515871

Group type: COMPARATOR
Intervention: Cold Pressor Test (CPT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dipyridamole infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: ACE-inhibitor infusion during CPT
Number of subjects: 20

Group type: COMPARATOR
Intervention: ACE-inhibitor infusion after dipyridamole
Number of subjects: 20
Study: 10428524

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study: 7779148

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lysine clonixinate
Number of subjects: 18
Study: 1692687

Group type: EXPERIMENTAL
Intervention: 40 mg propranolol (beta-blocker)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7025784

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride; treatment duration: three-week treatment periods.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo; treatment duration: three-week treatment periods.
Number of subjects: 0
Study: 29913108

Group type: EXPERIMENTAL
Intervention: Childcare-based intervention to reduce sitting time
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Childcare-based intervention
Number of subjects: 115
Study: 29354990

Group type: EXPERIMENTAL
Intervention: Alliance therapy group with scalp acupuncture, music therapy and rehabilitation
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination group with music therapy and rehabilitation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Rehabilitation group
Number of subjects: 76
Study: 25430812

Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg orally twice daily for 2 weeks starting on the day of surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: Loxoprofen orally three times daily for 2 weeks starting on the day of surgery
Number of subjects: 68
Study: 23417203

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation with load adjustable gain factors (PAV+)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 14
Study: 21793297

Group type: EXPERIMENTAL
Intervention: High-frequency denervation of facet joints
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no spinal surgery)
Number of subjects: 42
Study: 18854804

Group type: EXPERIMENTAL
Intervention: Group A (9 patients) with positive notching at week 20 and 24 in both pregnancies
Number of subjects: 14

Group type: COMPARATOR
Intervention: Group B (5 patients) with bilateral positive notching at week 20 and 24 only in the second pregnancy
Number of subjects: 14
Study: 16783500

Group type: EXPERIMENTAL
Intervention: Problem solving training (n = 32)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 63
Study: 12553384

Group type: EXPERIMENTAL
Intervention: Ropivacaine 150 mg diluted in 60 mL NaCl 0.9%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ropivacaine 150 mg diluted in 30 mL NaCl 0.9%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ropivacaine 150 mg diluted in 40 mL NaCl 0.9%
Number of subjects: 0
Study: 11008909

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 28
Study: 8866390

Group type: EXPERIMENTAL
Intervention: MgSO4
Number of subjects: 50
Study: 1355211

Group type: EXPERIMENTAL
Intervention: Atypical symptoms group (n=572)
Number of subjects: 572

Group type: COMPARATOR
Intervention: Typical symptoms group (n=2555)
Number of subjects: 572
Study: 6228080

Group type: EXPERIMENTAL
Intervention: Glycosaminoglycan polysulfate (GAGPS, Arteparon)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 140
Study: 31927702

Group type: EXPERIMENTAL
Intervention: Chloroquine therapy
Number of subjects: 20
Study: 31770012

Group type: EXPERIMENTAL
Intervention: Desflurane 0.6 MAC (Group D1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Desflurane 1.3 MAC (Group D2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Desflurane 2.0 MAC (Group D3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (before inhalation, T1)
Number of subjects: 60
Study: 28318848

Group type: EXPERIMENTAL
Intervention: Supervised physiotherapy in addition to a home exercise program
Number of subjects: 41

Group type: COMPARATOR
Intervention: Self-directed home exercise program
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups (Supervised physiotherapy and Self-directed home exercise)
Number of subjects: 41
Study: 27058481

Group type: EXPERIMENTAL
Intervention: Cognitive behavior-therapy anxiety-management (work-anxiety coping group, WAG)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Recreational activities (RG)
Number of subjects: 345
Study: 25233569

Group type: EXPERIMENTAL
Intervention: Pressure
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pressure and topical anesthetic (20% benzocaine)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pressure and cold (TFE)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no concurrent stimulation)
Number of subjects: 42
Study: 22234244

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) 1.25 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) 1.25 mg and intravitreal triamcinolone acetonide (IVT) 2 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Macular laser photocoagulation (MPC)
Number of subjects: 150
Study: 19515102

Group type: EXPERIMENTAL
Intervention: DVD delivery of falls prevention education
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Workbook delivery of falls prevention education
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Either DVD or workbook education
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 100
Study: 17328356

Group type: EXPERIMENTAL
Intervention: Positron emission tomography (PET) using the tracer 11C-methionine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 0
Study: 15229206

Group type: EXPERIMENTAL
Intervention: Drospirenone oral contraceptive (OC)
Number of subjects: 29
Study: 11409067

Group type: EXPERIMENTAL
Intervention: Self-adhesive breast prosthesis
Number of subjects: 101

Group type: COMPARATOR
Intervention: Traditional external breast prosthesis
Number of subjects: 101
Study: 9236408

Group type: EXPERIMENTAL
Intervention: Thrombomodulin gene mutations (GG‐9/‐10AT, G‐33A, C‐133A)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control subjects (matched for age, sex, and race)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Previously identified neutral polymorphism GCC/GTC coding for Ala/Val455
Number of subjects: 104
Study: 8138330

Group type: EXPERIMENTAL
Intervention: Captopril (4 mg/l mixed into the cardioplegic solution)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 3315268

Group type: EXPERIMENTAL
Intervention: Sustained-release theophylline (mean 11.2 mg/kg per day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sustained-release theophylline
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sustained-release terbutaline (mean 0.25 mg/kg per day)
Number of subjects: 19
Study: 29366658

Group type: EXPERIMENTAL
Intervention: Only clinical data (OCD)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Only lung ultrasound data (OLD)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both clinical and lung ultrasound data
Number of subjects: 76
Study: 27282133

Group type: EXPERIMENTAL
Intervention: Cinnamaldehyde (20 mg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nicotine (4 mg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination of cinnamaldehyde and nicotine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cinnamaldehyde responders
Number of subjects: 22
Study: 24722774

Group type: EXPERIMENTAL
Intervention: tenofovir-emtricitabine
Number of subjects: 254

Group type: COMPARATOR
Intervention: abacavir-lamivudine
Number of subjects: 254
Study: 24419925

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg and Tadalafil 5 mg
Number of subjects: 165

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg
Number of subjects: 165

Group type: COMPARATOR
Intervention: Tadalafil 5 mg
Number of subjects: 165
Study: 21415582

Group type: EXPERIMENTAL
Intervention: TACE-surgery group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Surgery group
Number of subjects: 32
Study: 19083404

Group type: EXPERIMENTAL
Intervention: Purple passion fruit peel extract (150 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16670244

Group type: EXPERIMENTAL
Intervention: Active intervention with a depression care manager for one year
Number of subjects: 1684

Group type: COMPARATOR
Intervention: Usual care for one year
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: Cognitive decline over two years
Number of subjects: 1684
Study: 14617058

Group type: EXPERIMENTAL
Intervention: Programme with ankle disc and functional strength training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Programme without ankle disc (functional strength training only)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Programme with ankle disc
Number of subjects: 16
Study: 10518002

Group type: EXPERIMENTAL
Intervention: Intake of 3.5 times the RDI of folic acid and B12
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma homocysteine (HC) below 7.5 micromol/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma vitamin B12 (B12) above 300 pmol/l
Number of subjects: 0
Study: 8523035

Group type: EXPERIMENTAL
Intervention: DHEAS serum levels in HC subjects
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CRT levels in HC subjects
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DHEAS/CRT ratio in HC subjects
Number of subjects: 11

Group type: COMPARATOR
Intervention: DHEAS serum levels in normal controls
Number of subjects: 11

Group type: COMPARATOR
Intervention: CRT levels in normal controls
Number of subjects: 11

Group type: COMPARATOR
Intervention: DHEAS/CRT ratio in normal controls
Number of subjects: 11
Study: 1646066

Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) and cisplatin (C)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: 5‐FU, C, and vinblastine (V)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Performance status 0 or 1
Number of subjects: 247

Group type: COMPARATOR
Intervention: Performance status 2 or greater
Number of subjects: 247

Group type: COMPARATOR
Intervention: Prior locoregional radiation therapy
Number of subjects: 247

Group type: COMPARATOR
Intervention: Performance status
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: 5‐FU, C, and V
Number of subjects: 247

Group type: COMPARATOR
Intervention: 5‐FU plus C
Number of subjects: 247
Study: 6275776

Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefotaxime with probenecid
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Moxalactam and ceftazidime
Number of subjects: 6
Study: 30450601

Group type: EXPERIMENTAL
Intervention: Thrombosomes
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (buffer solution)
Number of subjects: 15
Study: 27756351

Group type: EXPERIMENTAL
Intervention: Hockey FIT (12-week Active Phase and 40-week Maintenance Phase)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-List Control
Number of subjects: 80
Study: 25536254

Group type: COMPARATOR
Intervention: 33.5°C for 72 hours
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: 32.0°C for 72 hours
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: 33.5°C for 120 hours
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: 32.0°C for 120 hours
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: 120 hours group
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: 32.0°C group
Number of subjects: 364

Group type: COMPARATOR
Intervention: 72 hours group
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Longer cooling, deeper cooling, or both
Number of subjects: 364
Study: 23032205

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (HP) with hybrid light (HL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (HP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide (HP) with hybrid light (HL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide (HP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 15% carbamide peroxide (CP)
Number of subjects: 48
Study: 21291031

Group type: EXPERIMENTAL
Intervention: Sublingual ketorolac (30 mg/1 mL) and mepivacaine paracervical block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mepivacaine-only paracervical injection (standard group)
Number of subjects: 40
Study: 18558641

Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin A
Number of subjects: 4345

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4345
Study: 16114163

Group type: EXPERIMENTAL
Intervention: Diabetes care and management in private clinics
Number of subjects: 438
Study: 11803342

Group type: EXPERIMENTAL
Intervention: Surgical tracheostomy (ST)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Percutaneous dilatational tracheostomy (PDT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 50
Study: 10023614

Group type: EXPERIMENTAL
Intervention: Intensive outpatient or short-term residential treatment
Number of subjects: 21
Study: 7587740

Group type: EXPERIMENTAL
Intervention: Recombinant human macrophage colony-stimulating factor (rhM-CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: rhM-CSF
Number of subjects: 0
Study: 1690374

Group type: EXPERIMENTAL
Intervention: CSM
Number of subjects: 42

Group type: COMPARATOR
Intervention: CSM-dextran
Number of subjects: 42
Study: 7188827

Group type: EXPERIMENTAL
Intervention: Lactose-free (LF) chocolate dairy drink
Number of subjects: 87

Group type: COMPARATOR
Intervention: Lactose-containing (LC) dairy drink (4.5% lactose)
Number of subjects: 87
Study: 7052000

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside at the rate of 2 microgram per kilogram per minute during the payback period
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5% dextrose in water (D5W)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 38

Group type: COMPARATOR
Intervention: D5W
Number of subjects: 38
Study: 31128953

Group type: EXPERIMENTAL
Intervention: Smartphone game intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (baseline lifestyle counseling)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 27989255

Group type: EXPERIMENTAL
Intervention: Filmed social contact (FSC)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Self-instructional Internet search (INS)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control (PC games)
Number of subjects: 259
Study: 26799632

Group type: EXPERIMENTAL
Intervention: 200 mg BI 135585 (single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-200 mg BI 135585 (multiple doses)
Number of subjects: 0
Study: 25377907

Group type: EXPERIMENTAL
Intervention: Ibandronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 0
Study: 22722509

Group type: EXPERIMENTAL
Intervention: Agomelatine (AGO) 25-50 mg/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: Venlafaxine XR (VLX) 75-150 mg/d
Number of subjects: 60
Study: 20101013

Group type: EXPERIMENTAL
Intervention: 18-month multipurpose exercise program with special emphasis on exercise intensity (n = 123)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Wellness program (control group, n = 123)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: 18-month multipurpose exercise program
Number of subjects: 246

Group type: COMPARATOR
Intervention: Wellness program (control group)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: 10-year CHD risk for exercise group
Number of subjects: 246

Group type: COMPARATOR
Intervention: 10-year CHD risk for control group
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Direct health care costs per participant during the 18-month intervention for exercise group
Number of subjects: 246

Group type: COMPARATOR
Intervention: Direct health care costs per participant during the 18-month intervention for control group
Number of subjects: 246
Study: 17598865

Group type: EXPERIMENTAL
Intervention: Twice-weekly PUVA
Number of subjects: 28

Group type: COMPARATOR
Intervention: Thrice-weekly PUVA
Number of subjects: 28
Study: 16236163

Group type: EXPERIMENTAL
Intervention: Nasal lavage fluid from patients with allergic rhinitis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nasal lavage fluid from healthy volunteers
Number of subjects: 22
Study: 12236845

Group type: EXPERIMENTAL
Intervention: Enteric coated beads (1 x 200 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Enteric coated mini-tablets (4 x 50 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Buffered tablet (2 x 100 mg)
Number of subjects: 18
Study: 11341606

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg bd for five days presurgery
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 7488278

Group type: EXPERIMENTAL
Intervention: 5 mg cM-T412
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 10 mg cM-T412
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 50 mg cM-T412
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 2302375

Group type: EXPERIMENTAL
Intervention: Midazolam and fentanyl combination
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fentanyl alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam alone
Number of subjects: 60
Study: 7435246

Group type: EXPERIMENTAL
Intervention: Guar gum (15 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo or no medication
Number of subjects: 0
Study: 30387500

Group type: EXPERIMENTAL
Intervention: Narrative version of toolbox talks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard version of toolbox talks
Number of subjects: 0
Study: 27491293

Group type: EXPERIMENTAL
Intervention: Tele-CBT
Number of subjects: 19
Study: 26298832

Group type: EXPERIMENTAL
Intervention: High dose of vaporized cannabis (22 mg THC)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Low dose of vaporized cannabis (5.5 mg THC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 23954406

Group type: EXPERIMENTAL
Intervention: Restricted sleep (5.5-h time-in-bed)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Adequate sleep (8.5-h time-in-bed)
Number of subjects: 11
Study: 21138496

Group type: EXPERIMENTAL
Intervention: Vitadur‐N‐veneered crowns
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitadur‐α‐veneered crowns
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: VM7‐veneered crowns
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alumina cores (unveneered)
Number of subjects: 40
Study: 18372467

Group type: EXPERIMENTAL
Intervention: Low-grade glioma patients (transformers)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low-grade glioma patients (nontransformers)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison of rCBV changes between transformers and nontransformers
Number of subjects: 13
Study: 16630017

Group type: EXPERIMENTAL
Intervention: Spot chlorination
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control
Number of subjects: 127
Study: 12618744

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS) as initial long-term control therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11112027

Group type: EXPERIMENTAL
Intervention: Dual therapy (tacrolimus/corticosteroids)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Triple therapy (tacrolimus/corticosteroids/azathioprine)
Number of subjects: 491
Study: 9493932

Group type: EXPERIMENTAL
Intervention: Experimental foam surface
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard innerspring mattress
Number of subjects: 10
Study: 8323890

Group type: EXPERIMENTAL
Intervention: 5 mg plain bupivacaine (isobaric group)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 5 mg hyperbaric bupivacaine (hyperbaric group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Both groups (isobaric and hyperbaric)
Number of subjects: 65
Study: 3737634

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (PPA) 25 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (PPA) 75 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mazindol (MAZ) 0.5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mazindol (MAZ) 2.0 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: D-amphetamine (AMP) 10 mg
Number of subjects: 20